Spectrum Pharmaceuticals, Inc.
SPPI · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $10 | $0 | $0 | $23 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $2 | $0 | $0 | $12 |
| Gross Profit | $8 | $0 | $0 | $11 |
| % Margin | 82.3% | – | – | 46.9% |
| R&D Expenses | $42 | $87 | $109 | $79 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $39 | $60 | $60 | $61 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$9 |
| Operating Expenses | $81 | $148 | $170 | $141 |
| Operating Income | -$73 | -$148 | -$170 | -$144 |
| % Margin | -718.8% | – | – | -636.9% |
| Other Income/Exp. Net | -$5 | -$11 | -$2 | $174 |
| Pre-Tax Income | -$78 | -$158 | -$171 | -$145 |
| Tax Expense | $0 | $0 | -$0 | -$9 |
| Net Income | -$78 | -$158 | -$171 | -$135 |
| % Margin | -772.2% | – | – | -598.7% |
| EPS | -0.43 | -1.02 | -1.38 | -1.22 |
| % Growth | 57.8% | 26.1% | -13.1% | – |
| EPS Diluted | -0.43 | -1.02 | -1.38 | -1.22 |
| Weighted Avg Shares Out | 183 | 155 | 124 | 111 |
| Weighted Avg Shares Out Dil | 183 | 155 | 124 | 111 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $1 | $5 |
| Interest Expense | $1 | $0 | $0 | -$5 |
| Depreciation & Amortization | -$4 | $0 | $0 | $3 |
| EBITDA | -$77 | -$147 | -$169 | -$155 |
| % Margin | -761.9% | – | – | -683.6% |